Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Change in Receivables (2017 - 2025)

BeOne Medicines (BEIGF) has disclosed Change in Receivables for 9 consecutive years, with -$2.3 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 101.86% to -$2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165.0 million through Dec 2025, down 49.93% year-over-year, with the annual reading at $165.0 million for FY2025, 49.93% down from the prior year.
  • Change in Receivables for Q4 2025 was -$2.3 million at BeOne Medicines, down from $93.9 million in the prior quarter.
  • The five-year high for Change in Receivables was $353.8 million in Q4 2021, with the low at -$292.6 million in Q1 2022.
  • Average Change in Receivables over 5 years is $40.1 million, with a median of $30.9 million recorded in 2024.
  • The sharpest move saw Change in Receivables surged 263963.43% in 2021, then plummeted 1336.7% in 2022.
  • Over 5 years, Change in Receivables stood at $353.8 million in 2021, then plummeted by 105.48% to -$19.4 million in 2022, then surged by 330.96% to $44.8 million in 2023, then surged by 180.61% to $125.7 million in 2024, then crashed by 101.86% to -$2.3 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$2.3 million, $93.9 million, and $41.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.